InsidersTradesSigma
Explore the full record of transactions filed by Tourangeau Greg, Contrôleur. Officer active across 1 companies, notably Fulcrum Therapeutics, Inc.. Cumulatively, 1 filings have been logged. The latest transaction was disclosed on 6 May 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
1 of 1 declaration
Greg Tourangeau is the Controller of Fulcrum Therapeutics, Inc. In this role, he is responsible for overseeing the company's accounting and financial operations. His financial expertise is essential in ensuring compliance and accuracy in financial reporting. Greg Tourangeau works closely with the management team to ensure the financial health of the company.